# Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

Study · id `cardio:ct-nct05199662` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05199662](<https://clinicaltrials.gov/study/NCT05199662>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05199662

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 466 participants.

## Technical summary

Registry record NCT05199662. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-20 (actual); primary completion 2026-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 466 participants (planned count; ClinicalTrials.gov record NCT05199662, source copy `cardio:ctgov-nct05199662-2025-04-04`, retrieved 2026-10-26)
- Started: 2022-01-20 (actual) (ClinicalTrials.gov record NCT05199662, source copy `cardio:ctgov-nct05199662-2025-04-04`, retrieved 2026-10-26)
- Primary completion: 2026-07 (anticipated) (ClinicalTrials.gov record NCT05199662, source copy `cardio:ctgov-nct05199662-2025-04-04`, retrieved 2026-10-26)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05199662, source copy `cardio:ctgov-nct05199662-2025-04-04`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT05199662, source copy `cardio:ctgov-nct05199662-2025-04-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05199662-2025-04-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
- Acronym: EXTEND-IV
- Condition: Ischemic Stroke, Acute
- Intervention (Drug): Intravenous tenecteplase
- Intervention (Drug): Placebo
- Lead sponsor: Hospital Moinhos de Vento
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Brazil
- Collaborator class: OTHER\_GOV
- Collaborator: Boehringer Ingelheim
- Collaborator class: INDUSTRY
- Collaborator: Brainomix Limited
- Collaborator class: INDUSTRY
- Collaborator: iSchemaView, Inc
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: Hospital Moinhos de Vento (`cardio:org-hospital-moinhos-de-vento`)
- Registry lists this organization as a collaborator: Ministry of Health, Brazil (`cardio:org-ministry-of-health-brazil`)
- Registry lists this organization as a collaborator: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

## Provenance

Content hash: 8e4861c4cfe027b11240775fe291312363d7b7a3df177c9041037d263669a123
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
